YANCOPOULOS GEORGE — SEC Form 4 filings
SEC reporting owner CIK 1226690. 8 Form 4 filings on record with FilingPulse; latest filed 2026-01-05.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-02-20 to 2026-01-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 38 legs across 3 filings — 116,848 shares, $112,593,472 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
- Largest priced transaction: sale of 16,848 shares @ $900.00 ($15,163,200) in REGENERON PHARMACEUTICALS, INC., filed 2024-05-01.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC. (REGN) | Bd. Co-Chair, President & CSO, Director | 8 | — | 38 legs · 116,848 sh · $112,593,472 | 13 |
Form 4 filings — YANCOPOULOS GEORGE
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-01-05 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 28,570 @ $0 · Tax withholding (F): 28,570 @ $772.09 · Option exercise (M): 28,570 (derivative) @ $0 | EDGAR |
| 2025-12-11 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 146,815 @ $555.67 · Tax withholding (F): 131,874 @ $701.51 · Option exercise (M): 146,815 (derivative) @ $0 | EDGAR |
| 2024-06-12 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Gift (G): 75,799 @ $0 · Gift (G): 37,900 @ $0 | EDGAR |
| 2024-05-17 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 111 @ $965.69 · Sale (S): 782 @ $966.29 · Sale (S): 1,428 @ $967.45 · Sale (S): 3,387 @ $968.43 · Sale (S): 1,930 @ $969.14 · Sale (S): 846 @ $970.36 · +19 more | EDGAR |
| 2024-05-17 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 907 @ $967.40 · Sale (S): 3,213 @ $968.44 · Sale (S): 9,501 @ $969.39 · Sale (S): 4,669 @ $970.26 · Sale (S): 4,922 @ $971.56 · Sale (S): 790 @ $972.22 · +6 more | EDGAR |
| 2024-05-01 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 16,848 @ $900 | EDGAR |
| 2024-05-01 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Gift (G): 36,296 @ $0 · Gift (G): 18,148 @ $0 | EDGAR |
| 2024-02-20 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 172,723 @ $399.66 · Tax withholding (F): 123,601 @ $953.83 · Option exercise (M): 172,723 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1226690 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →